Six insurers under the Blue Cross Blue Shield umbrella are suing CVS Health, claiming the pharmacy chain inflated generic drug prices, FierceHealthcare reports.
“Had CVS been open and notorious about its fraudulent pricing scheme, it never would have succeeded—plaintiffs would have insisted that CVS submit the correct [usual & customary] price,” the suit alleges. “Indeed, while carrying out this scheme, CVS internally feared that third-party payors would learn of the deception and demand correction.”
CVS Spokesperson Michael DeAngelis in a statement to FierceHealthcare called the allegations “baseless.”
To read the full report on FierceHealthcare, click here.